Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: A Study of Bleeding and Treatment in Participants With Von Willebrand Disease

View source ↗

Summary

This clinical trial update describes a study on bleeding and treatment in people with Von Willebrand disease that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hemab ApS | Conditions: Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1 | Status: RECRUITING